Competition Law and Strategic Industry Competitiveness

1. Introduction

Strategic industry competitiveness refers to the ability of industries that are economically, technologically, or nationally significant to remain productive, innovative, resilient, and internationally competitive. Such industries may include semiconductors, energy, telecommunications, artificial intelligence, defence, pharmaceuticals, critical minerals, transport, financial infrastructure, and advanced manufacturing.

Competition law plays a dual role: it prevents firms from protecting their positions through anticompetitive conduct while allowing legitimate cooperation, investment, and innovation that strengthen industrial capabilities.

The central challenge is to distinguish between legitimate efforts to develop globally competitive industries and conduct that entrenches market power, excludes rivals, raises prices, or prevents new technologies from emerging.

For example, cooperation between semiconductor manufacturers to develop common technical standards may accelerate innovation. However, an agreement among those manufacturers to divide customers, restrict production, or exclude independent chip designers may undermine competition.

2. Objectives of competition law in strategic industries

Promoting innovation: Encourage research, technological development, and competition between alternative technologies.

Protecting market access: Prevent dominant firms from unfairly excluding new entrants, smaller businesses, and foreign competitors where applicable law protects such access.

Improving productivity: Encourage firms to reduce costs, improve quality, and use resources efficiently.

Maintaining supply-chain resilience: Examine whether exclusive supply arrangements or acquisitions create excessive dependence on a single supplier.

Facilitating investment: Permit legitimate joint ventures, research partnerships, and infrastructure-sharing arrangements that generate demonstrable benefits.

Supporting consumer and business welfare: Prevent excessive pricing, reduced choice, lower quality, and innovation suppression resulting from anticompetitive conduct.

Preserving international competitiveness: Help domestic firms compete through productivity and innovation rather than protection from rivalry.

Competition law does not necessarily require every strategic industry to contain numerous small firms. Some industries have substantial economies of scale and high fixed costs. The objective is to prevent firms from acquiring or exercising market power through unlawful means while preserving the benefits of efficient scale.

3. Legal framework

The applicable rules depend on the jurisdiction. The following principles are especially relevant in the European Union, the United Kingdom, the United States, and other systems with established competition regimes.

Strategic competitiveness versus industrial protection

A government may have legitimate reasons to promote energy security, technological capacity, defence readiness, or supply-chain resilience. However, these objectives do not automatically justify cartel behaviour or anticompetitive exclusion.

A sound legal assessment should consider:

Whether the industry is genuinely strategic and what public objective is being pursued.

Whether the challenged conduct restricts competition.

Whether claimed benefits are verifiable and likely to materialise.

Whether less restrictive alternatives exist.

Whether any exemption or public-interest defence is expressly permitted by the applicable law.

Whether the intervention is proportionate, transparent, and subject to review.

4. Key case laws on strategic industry competitiveness

The following cases illustrate how competition law addresses dominance, industrial consolidation, innovation, access to critical inputs, and the preservation of effective rivalry. They arise from different jurisdictions, so their legal rules must be applied according to the relevant national or regional framework.

Case 1: United Brands Company v Commission (1978)

Citation: Case 27/76, Court of Justice of the European Communities.

Facts: United Brands held a powerful position in the banana market. The dispute concerned its commercial practices, including discriminatory pricing and restrictions on dealings with certain distributors.

Legal principle: A dominant undertaking has a special responsibility not to impair genuine competition. Conduct that exploits or excludes trading partners may constitute an abuse of dominance under the applicable rules.

Relevance to strategic industries: A company controlling a vital commodity or distribution channel cannot justify discriminatory conduct merely by pointing to its commercial importance. Dominant suppliers of energy, industrial inputs, or essential technologies must comply with competition law.

Case 2: Commercial Solvents v Commission (1974)

Citation: Joined Cases 6/73 and 7/73, Court of Justice of the European Communities.

Facts: Commercial Solvents controlled supplies of a chemical raw material used in downstream production. Its refusal to continue supplying a downstream customer threatened that customer's ability to compete.

Legal principle: A dominant undertaking's refusal to supply may constitute an abuse where it threatens to eliminate competition in a downstream market, subject to the applicable legal conditions.

Relevance to strategic industries: The case is significant for critical minerals, pharmaceutical ingredients, semiconductor materials, and other industries dependent on specialised upstream inputs. Control of an important resource should not become a mechanism for eliminating downstream rivals.

Case 3: United States v. Philadelphia National Bank (1963)

Citation: 374 U.S. 321, Supreme Court of the United States.

Facts: The case concerned a proposed merger between major Philadelphia banks and the competitive consequences of increasing concentration in local banking.

Legal principle: The Supreme Court recognised that a merger increasing concentration in a highly concentrated market could be presumed unlawful under Section 7 of the Clayton Act, subject to the governing legal analysis and rebuttal.

Relevance to strategic industries: Banking and financial infrastructure support investment throughout the economy. The case demonstrates why regulators must consider whether consolidation removes independent competitors and increases entry barriers, rather than assuming that larger institutions necessarily produce better competitive outcomes.

Case 4: Brown Shoe Co. v. United States (1962)

Citation: 370 U.S. 294, Supreme Court of the United States.

Facts: The case involved a merger between footwear businesses and the competitive implications of increased concentration across manufacturing and retail distribution.

Legal principle: Merger analysis may consider the structure of the market, trends toward concentration, barriers to entry, and the effects of consolidation at different levels of a supply chain.

Relevance to strategic industries: A merger may strengthen a firm's control over both manufacturing and distribution. In industries such as batteries, electric vehicles, and advanced manufacturing, authorities should examine whether vertical integration produces genuine efficiencies or forecloses competing suppliers and distributors.

Case 5: United States v. Microsoft Corp. (2001)

Citation: 253 F.3d 34, United States Court of Appeals for the District of Columbia Circuit.

Facts: Microsoft was challenged over conduct used to maintain its position in operating systems, including restrictions affecting browser competition.

Legal principle: The appellate court upheld important findings concerning exclusionary conduct under Section 2 of the Sherman Act, while reversing or remanding certain aspects of the lower court's judgment.

Relevance to strategic industries: The case illustrates how control over a foundational technological platform can influence competition in adjacent markets. Similar concerns may arise where a company controls an operating system, cloud infrastructure, AI development platform, or other essential technological ecosystem.

Strategic importance does not immunise a company from scrutiny when it uses control over a platform to restrict competitive opportunities.

Case 6: European Commission v Intel Corp. (2024)

Citation: Case C-240/22 P, Court of Justice of the European Union.

Facts: The dispute concerned the European Commission's assessment of Intel's conditional rebates and the legal standards for establishing exclusionary abuse of dominance.

Legal principle: The Court addressed the treatment of the as-efficient-competitor test and the requirements governing judicial review of the Commission's assessment. The judgment must be read alongside the earlier Intel proceedings, including Case C-413/14 P.

Relevance to strategic industries: Semiconductor markets depend on substantial investment, economies of scale, and technological innovation. Competition authorities must distinguish legitimate price competition from rebate arrangements capable of excluding equally efficient competitors. They must also assess the evidence and economic circumstances rigorously.

Case 7: Dow/DuPont merger decision (2017)

Citation: European Commission, Case M.7932.

Facts: The proposed merger combined major businesses in the agrochemical and materials sectors. The Commission examined effects on product-market competition and innovation.

Legal principle: Merger control can address the loss of independent research and development capabilities, not merely immediate price increases. The Commission required significant divestitures, including DuPont's global research and development business, to address identified competition concerns.

Relevance to strategic industries: Research-intensive sectors depend on independent innovation pathways. Consolidation may reduce the number of firms developing alternative products and technologies, even when the immediate effect on prices is uncertain.

The case demonstrates that preserving innovation competition can be central to protecting the long-term competitiveness of a strategic industry.

Case 8: Illumina/GRAIL merger proceedings

Citation: European Commission, Case M.10188; subsequent European Union court proceedings.

Facts: Illumina, a provider of next-generation sequencing systems, acquired GRAIL, which developed blood-based cancer detection tests. The Commission examined whether Illumina could use its position in sequencing technology to disadvantage rival developers of cancer-detection tests.

Legal principle: Merger analysis may examine whether control over an upstream technology enables a merged firm to restrict access, increase costs, degrade quality, or otherwise weaken competition in downstream markets.

The proceedings also raised important questions about the European Commission's jurisdiction to review certain transactions that did not meet traditional merger-notification thresholds.

Relevance to strategic industries: The case demonstrates the importance of access to critical technological infrastructure in biotechnology and healthcare. Where a single company controls an important input, regulators should consider whether an acquisition threatens emerging competitors and future innovation.

The jurisdictional questions in this case are distinct from the substantive competition concerns; the precise legal position depends on the applicable judgments and subsequent regulatory framework.

5. Major competition concerns in strategic industries

A. Semiconductor and advanced technology concentration

High capital expenditure and specialised intellectual property may create substantial entry barriers. Authorities should examine acquisitions of potential innovators, exclusive access to chip designs, discriminatory licensing, and restrictions on interoperability.

B. Energy and critical infrastructure

Network industries often contain natural monopolies. Regulation and competition law may need to work together to address discriminatory grid access, exclusionary infrastructure arrangements, cross-subsidisation, and restrictions on independent energy suppliers.

C. Pharmaceuticals and biotechnology

Patent protection can encourage innovation, but strategic acquisitions, exclusionary licensing, certain patent settlements, or restrictions on competing research may reduce future rivalry. Authorities should evaluate innovation incentives without treating every patent-based advantage as unlawful.

D. Artificial intelligence and cloud computing

Control over compute capacity, cloud infrastructure, training data, distribution channels, and foundation models can create dependencies. Competition assessments may examine exclusive cloud arrangements, discriminatory API access, tying, and acquisitions that eliminate emerging competitors.

6. Strategic industry competitiveness and merger control

Merger control is particularly important because a transaction may permanently remove a competitive constraint. The central question is not whether a larger company would be more powerful internationally, but whether the transaction is likely to harm competition within the relevant legal framework.

Regulators generally examine:

Horizontal effects: Whether the transaction combines close competitors.

Vertical effects: Whether the merged firm can restrict access to essential inputs or customers.

Conglomerate effects: Whether the firm can leverage power in one market into another.

Innovation effects: Whether independent research programmes, future products, or potential entrants are eliminated.

Resilience effects: Whether concentration creates significant supply risks or dependence, insofar as these considerations are relevant under the applicable legal test.

Efficiencies: Whether verifiable merger-specific benefits are likely to improve output, quality, innovation, or costs and can be considered under the relevant law.

A government may believe that a domestic firm needs scale to compete internationally. However, international competitiveness is not automatically a defence to a merger that substantially harms domestic or regional competition.

Possible remedies include divestiture, licensing, access obligations, interoperability requirements, and restrictions on discriminatory conduct. Structural remedies are often preferred when they can effectively restore independent competitive pressure; behavioural remedies require careful monitoring and enforcement.

7. Strategic industrial policy, subsidies, and competition

Public support can help develop emerging technologies, secure critical supply chains, and finance research with significant social benefits. But selective subsidies, guarantees, preferential access, or state-backed financing can distort competitive conditions.

In the European Union, Article 107 TFEU generally prohibits incompatible State aid, subject to applicable exceptions and compatibility rules. In the United Kingdom, subsidy control is governed by its own statutory framework. Other jurisdictions have different rules and institutional arrangements.

A competition-compatible industrial policy should:

Identify a specific market failure or strategic public objective.

Establish transparent eligibility criteria.

Avoid unnecessarily favouring a particular incumbent.

Use competitive procurement where appropriate.

Set measurable performance and investment conditions.

Include review, recovery, or sunset mechanisms where justified.

Monitor the effects on entry, innovation, prices, and market concentration.

For example, a public programme supporting semiconductor research could fund collaborative facilities accessible on fair terms to qualified firms. An arrangement that permanently reserves a publicly financed facility for one favoured producer could instead entrench that producer's market position.

The legal assessment depends on the structure of the programme, the relevant competition and subsidy rules, and the evidence of market effects.

8. Framework for assessing strategic industry competitiveness

The following analytical framework can be used by competition authorities, policymakers, researchers, and corporate compliance teams.

Stage 1 — Identify the strategic objective

Technology leadership, supply security, resilience, productivity, or innovation

Stage 2 — Assess market structure

Market shares, entry barriers, buyer power, substitution, and control of essential inputs

Stage 3 — Identify the conduct or transaction

Merger, exclusive dealing, refusal to supply, cartel, subsidy, or joint venture

Stage 4 — Evaluate competitive effects

Prices, output, quality, innovation, access, efficiency, and potential foreclosure

Stage 5 — Select a proportionate response

Clearance, conditions, targeted remedies, enforcement, or prohibition under the applicable law

9. Measuring strategic industry competitiveness

Competitiveness should not be measured solely by market share or the size of national champions. A balanced assessment combines short-term performance with long-term productive and innovative capacity.

These indicators should be interpreted together. High concentration does not automatically prove unlawful conduct, and high R&D spending does not establish that a merger or restrictive agreement benefits competition.

10. Principal legal and policy challenges

First, national champions versus competitive markets. Governments may seek globally successful firms, but insulating incumbents from rivalry can weaken their incentives to innovate and become more efficient.

Second, short-term efficiency versus long-term innovation. A merger may reduce immediate costs while eliminating a future source of disruptive competition. Authorities need credible evidence about both effects.

Third, resilience versus duplication. Maintaining multiple suppliers can improve security but may increase costs. Policy should distinguish justified resilience measures from unnecessary restrictions on competition.

Fourth, public intervention versus regulatory capture. Subsidies and sector-specific exemptions may become instruments for protecting favoured firms. Transparent criteria and independent oversight reduce this risk.

Fifth, technological dependence. Control of proprietary standards, APIs, data, cloud capacity, or specialised components may allow a firm to influence an entire industrial ecosystem. Access remedies should be targeted and legally justified, rather than imposed indiscriminately.

Sixth, cross-border enforcement. Strategic industries operate across jurisdictions. Divergent merger decisions, subsidy regimes, and remedies can create uncertainty and conflicting obligations. International cooperation can improve consistency without eliminating legitimate differences between legal systems.

11. Conclusion

Competition law is a central instrument for strengthening strategic industry competitiveness, but its objective is not simply to create the largest possible domestic companies. It is to preserve the conditions under which firms can achieve scale, innovate, invest, and compete effectively without unlawfully excluding rivals.

The cases of United Brands, Commercial Solvents, Philadelphia National Bank, Brown Shoe, Microsoft, Intel, Dow/DuPont, and Illumina/GRAIL illustrate different dimensions of this challenge: dominance, critical inputs, market concentration, technological control, exclusionary pricing, and the protection of innovation.

The most effective policy combines rigorous competition enforcement with carefully designed industrial support. Strategic industries become more sustainable when firms gain competitive advantages through productivity, research, investment, and technological excellence—not through cartels, unjustified exclusion, or the permanent protection of incumbents.